| Names | |
|---|---|
| Preferred IUPAC name | (5R)-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one |
| Other names | Ascorbic Acid L-ascorbic acid Ascorbate Vitamin C Powder Sodium Ascorbate Calcium Ascorbate |
| Pronunciation | /ˈvaɪ.tə.mɪn siː/ |
| Identifiers | |
| CAS Number | 50-81-7 |
| Beilstein Reference | 2053776 |
| ChEBI | CHEBI:29073 |
| ChEMBL | CHEMBL112 |
| ChemSpider | 5757 |
| DrugBank | DB00126 |
| ECHA InfoCard | 100.001.291 |
| EC Number | 3.2.1.17 |
| Gmelin Reference | 55438 |
| KEGG | C00072 |
| MeSH | D015847 |
| PubChem CID | 54670067 |
| RTECS number | WGK3850000 |
| UNII | SQE6VB453K |
| UN number | UN3077 |
| CompTox Dashboard (EPA) | DTXSID5027862 |
| Properties | |
| Chemical formula | C6H8O6 |
| Molar mass | 176.12 g/mol |
| Appearance | colorless to slightly yellow crystal or powder |
| Odor | Odorless |
| Density | 0.6 g/cm3 |
| Solubility in water | Soluble in water |
| log P | -1.85 |
| Acidity (pKa) | 4.2 |
| Basicity (pKb) | 8.34 |
| Magnetic susceptibility (χ) | Magnetic susceptibility (χ) of Vitamin C: −59.0×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.62 |
| Viscosity | Medium |
| Dipole moment | 4.8804 Debye |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 437.9 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -463.2 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -2115 kJ/mol |
| Pharmacology | |
| ATC code | A11GA01 |
| Hazards | |
| Main hazards | Not a hazardous substance or mixture. |
| GHS labelling | GHS07, Warning, H315, H319, H335 |
| Pictograms | 🧴🍊💊 |
| Signal word | No signal word |
| Hazard statements | No hazard statements. |
| Precautionary statements | Keep out of reach of children. If you are pregnant, nursing, taking medication, or have a medical condition, consult your physician before use. Store in a cool, dry place. Do not use if seal under cap is broken or missing. |
| Flash point | 54°C |
| Autoignition temperature | 660 °C |
| Lethal dose or concentration | LD50 (oral, rat): 11,900 mg/kg |
| LD50 (median dose) | 11,900 mg/kg (oral, rat) |
| NIOSH | VTN35000 String |
| PEL (Permissible) | 10 mg/m³ |
| REL (Recommended) | 90 mg |
| Related compounds | |
| Related compounds | Dehydroascorbic acid Ascorbyl palmitate Calcium ascorbate Magnesium ascorbate Sodium ascorbate Ascorbyl phosphate Ascorbyl stearate |
| Category | Details |
|---|---|
| Product Name & IUPAC Name |
Product Name: Vitamin C IUPAC Name: (5R)-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one |
| Chemical Formula | C6H8O6 |
| Synonyms & Trade Names |
Ascorbic Acid, L-Ascorbic Acid Several trade names and proprietary marks exist depending on grade, supplier arrangements, and end-use registration. Industrial grades may be referenced as USP, EP, BP, JP, or food/feed grade according to compliance certification, and cosmetic grades may appear under separate INCI designations. |
| HS Code & Customs Classification |
HS Code: 293627 Customs definition aligns Vitamin C under "Other vitamins and their derivatives, unmixed." Regional tariff sub-codes distinguish between forms (pure vs. preparation, bulk vs. retail, pharma vs. food/feed/cosmetics), and commercial documentation typically references the unified code but requires explicit grade or end-use statement for customs processing. |
Industrial ascorbic acid manufacture pivots on established fermentation and chemical synthesis pathways. The process route is tied to raw material access, compliance requirements, scalability, and impurity load. Most production lines use D-glucose of defined purity and source, balancing conversion efficiency with downstream purification requirements. Sourcing logic is driven by price stability, trace element profile, and batch-to-batch uniformity.
Manufacturing selects route and in-process controls according to impurity tolerance determined by target application. Reliance on a two-step fermentation (Reichstein process or modern biocatalytic conversion) introduces organic byproducts which require rigorous separation and washing steps. Final purification strategy (crystallization, filtration, drying) targets residual heavy metals, organic acids, and isomeric impurities in accordance with food/pharma regulatory expectations.
In-process testing benchmarks color, particle form, moisture, and assay trending. Specifications for ascorbic acid content, loss on drying, microbial load, and heavy metal contaminants are grade- and region-dependent; the manufacturer adjusts analytical acceptance criteria for food, pharmaceutical, or feed grades, directly in dialogue with QA/RA and end-use client specifications.
Batch release relies on cumulative data from in-process and lot-based end testing. DNA for traceability is included on the COA, and production maintains deviation logs for all quality-impacting variables. Customs classification is assigned at shipment allocation, not cradle-to-gate, and often requires supplying supporting analytical data and compliance documentation as mandated by importing authorities.
Vitamin C is produced as a crystalline powder or granule, with form and particle size adjusted depending on intended use—pharmaceutical, food, or feed. Color ranges from colorless to pale yellow, influenced by raw material lot and drying process. No distinct odor is detected in standard grades. Melting starts around 190–192°C for pure ascorbic acid. Boiling point is not practically observed due to decomposition; heating above melt rapidly degrades the compound. Density is grade and compaction-dependent; granular products pack differently than fine powders, impacting dissolution behavior.
As a reducing agent, ascorbic acid degrades quickly under light, moisture, and oxygen exposure. Stability depends on grade—coated forms, for example, extend shelf life in sensitive formulations. Browning or loss of potency results from oxidation, aggravated by metal ions (iron, copper) and elevated temperature. Food and pharma applications often specify antioxidant protectants or nitrogen blanketing for shelf life extension.
Solubility in water exceeds 33 g/100 mL at ambient temperature, influenced by crystal form and milling conditions. Solutions require fresh preparation in applications prioritizing bioactivity, as dissolved ascorbic acid decomposes faster, especially when exposed to trace metal ions. Solubility in ethanol is limited; nearly insoluble in nonpolar solvents. For high purity applications, solution preparation often involves water-for-injection or deionized water with chelators.
| Parameter | Pharma Grade | Food Grade | Feed Grade |
|---|---|---|---|
| Assay (as C6H8O6) | Defined by pharmacopeia | Codex or FCC limits | Less stringent, feed-optimized |
| Loss on Drying | Tighter limits | Flexible per customer | Specification per application |
| Heavy Metals | Strict per monograph | Food law based | Feed additive standard |
| Arsenic, Lead | Strict monitoring | Food regulations | Species-specific risk |
Grade selection is application-driven. Impurity and residual solvent requirements align with regulatory authority and final product risk profile.
Process impurities include isomers, oxidation byproducts, and residual solvents. Most originate from raw material purity and process step optimization. Typical values depend on synthesis efficiency, purification depth, and intended market (e.g., strictest for parenteral use). Final release standards align with pharmacopeial or food additive monographs as specified by the customer.
Pharmaceutical users reference national or international pharmacopeias—USP, EP, JP. Food processors follow FCC, E300 and Codex standards. Feed grades align with FAMI-QS or QS systems. Methods include titration, HPLC, UV, and limit tests for trace metals, often verified by independent QC lab for batch release.
Production begins with corn starch or sorbitol, selected based on regional availability, price stability, and traceability for allergen risk management. Only non-GMO sources qualify for certain markets.
Mainstream manufacturing uses the Reichstein or modern two-step fermentation pathway. The classic Reichstein method involves catalytic hydrogenation, selective oxidation, and ring closure. Modern fermentation routes employ bacterial cultures to reduce stages and waste, though fermentation control requires higher investment in process analytics. Route selection balances cost, environmental compliance, and end-user demand for sustainability documentation.
Critical steps include controlled pH, temperature, and time to limit racemization and excessive byproduct formation. Impurities often stem from incomplete conversion, raw material contaminants, or thermal degradation. Purification typically involves crystallization and washing, with continuous monitoring of critical contaminants and polymorph distribution to ensure yield and compliance.
Release parameters include assay, moisture, heavy metals, microbial load, and particle size distribution. Every batch undergoes full panel testing, with additional confirmatory tests for regulated markets or customer-specific requirements. Deviations prompt investigation by production, QA, and QC to ensure traceability in case of non-conformance.
Ascorbic acid undergoes oxidation-reduction, esterification with fatty acids, and glycosylation for specialty applications. The reactivity profile enables the synthesis of derivatives for pharmaceutical and food preservative use. Downstream modifications are selected according to required solubility, stability, or release profile in the target formulation.
Oxidation reactions depend on aerobic or anaerobic conditions, often accelerated by elevated temperature or catalytic metal traces. Esterification employs acid catalysts and controlled moisture exclusion, with reaction temperature and time adjusted based on desired yield and product form. Processing solvents and temperatures are dictated by downstream target impurities and application restrictions.
Products such as ascorbyl palmitate, sodium ascorbate, and calcium ascorbate are manufactured by tailored chemical modification. Form selection reflects user preference—e.g., oil-soluble ascorbyl esters for cosmetic use, mineral ascorbates for neutral-taste or buffered supplements.
Stability is maximized by low humidity, cool temperatures, limited light exposure, and oxygen exclusion. Nitrogen-blanketed drums and foil-laminate packaging extend shelf life for sensitive applications—common in pharma and high-end food sectors. Opened containers require rapid use or re-sealing with inert gas to minimize potency loss.
Material selection prevents catalytic degradation; plastics must resist diffusion of oxygen and moisture. Metal packaging only suits lined, food-grade interiors. Improper contact with copper or iron accelerates degradation.
Commercial shelf-life claims depend on grade, packaging technology, and containment integrity. Typical signs of degradation include yellowing, caking, and assay reduction detected through routine QC sampling. Specifications for shelf life often align with customer or regulatory requirements.
Vitamin C typically has low acute toxicity, but specific hazard class depends on region and declarations under GHS. Minor irritation may occur on contact with eyes or mucous membranes at high concentrations.
Non-flammable and non-explosive under anticipated storage and handling. Avoid dust generation to reduce inhalation exposure, especially during large-scale or automated packaging. Protective measures—gloves, dust masks, goggles—are standard in packaging and blending operations.
Acute toxicity is low. No significant systemic toxicity at typical industrial exposure levels, though chronic exposure limits may be set according to local occupational health regulations. Handling guidelines focus on housekeeping to prevent slip and inhalation hazards. Spill response includes vacuum collection and careful avoidance of moisture exposure. Emergency procedures follow site-specific documentation and regulatory requirements.
Vitamin C (ascorbic acid) production scales with installed fermentation reactor capacity, downstream processing throughput, and raw material continuity. The actual annual output varies by season, maintenance schedules, and allocation strategy between food, feed, and pharmaceutical grades. Fluctuations in corn supply and internal fermentation efficiency drive raw material availability. Manufacturers with integrated feedstock sourcing and energy optimization typically deliver higher batch consistency and buffer short-term market shocks.
Standard lead times are tied directly to filling schedules, purification queue length, batch test turnaround, and required documentation. For established commercial customers, routine product grades are available based on rolling forecasts and contracted volume. MOQ fluctuates depending on packaging format, grade, and customer qualification status. Initial supply to new customers or for specialty grades usually undergoes additional release testing, extending lead time relative to basic grades destined for granular feed or industrial food applications.
Packaging format is grade- and region-dependent. Food-grade and feed-grade are normally supplied in multi-layer kraft paper bags, FIBCs, or composite drums with internal liners for moisture barrier. Higher purity or pharmaceutical grades often require HDPE or aluminum-lined drums to prevent contamination and degradation during transit. Custom packaging can be negotiated but must comply with local transport regulations and downstream risk assessments.
Shipment methods include bulk by land or sea, and LCL/FCL for smaller volumes. Incoterms depend on customer relationship and risk-sharing agreements. Full container loads afford better cost efficiency and reduced exposure to transit-related loss. Payment structure—advance, LC, or credit—varies by customer reliability, country risk, and previous transaction history.
Vitamin C fermentation depends on raw corn or glucose as the primary input, with cost pass-through linked to major grain-producing economies. Price volatility in corn—often triggered by crop failures, domestic policy changes, or shipping bottlenecks—has the greatest impact on ascorbic acid bottom-line cost. Energy input, fermentation catalyst sourcing, and effluent treatment compliance add further layers to production costs.
Short-term price swings track with seasonal grain market disruptions, surges in energy prices, or shifts in bioreactor technology yield efficiency. External factors such as labor dispute impacts or force majeure declarations at major Chinese or Indian producers can abruptly spike global prices.
Wholesale price varies by product grade—feed, food, and pharmaceutical. The cost structure for pharmaceutical grade reflects additional purification, trace impurity removal, and release documentation. Larger pack formats are priced lower per ton but require rigorous moisture and contamination controls. Certification—Halal, Kosher, allergen status, and regional GFSI compliance—adds further differentiation, especially for multinational buyers requiring direct-to-dosage or strict audit trails.
Main production is concentrated in China, with significant secondary volumes from India and select EU sites. US and Japanese buyers source both domestically and globally, with supply contracts tightly tied to traceability and compliance standards. Demand in the past two years has grown in immunity-boosting supplement sectors and animal nutrition. Supply chain shocks in 2020-2022 triggered spot price volatility, but capacity expansions in Asia and supply rationalization since late 2023 improved average delivery reliability.
| Region | Supply Dynamics | Demand Characteristics |
|---|---|---|
| US | Limited domestic fermentation; reliant on imports. Regulatory documentation and traceability audits drive cost. | High share to food and pharmaceuticals; less flexible with grade substitution. |
| EU | Strict REACH and EFSA standards; moderate local output, high import dependency. | Food additive, supplement, and veterinary medicine remain main segments. |
| JP | High-value niche grades; advanced QC and multi-step purification dominate. | Consumer preference for certified domestic product; high traceability requirements. |
| IN | Export-oriented growth; rapidly improving process scale and documentation. | Supplying Asia and MEA with cost-competitive intermediate and feed grades. |
| CN | Holds majority of global capacity; subject to government policy, energy rationing, environmental enforcement. | Internal demand stable; global exports dictated by domestic policy shifts. |
Wholesale vitamin C prices have stabilized since the sharp fluctuations of 2020-2022 but remain vulnerable to grain market and energy input shocks. By 2026, moderate capacity expansion in Asia and further process optimization reduce volatility, though cost pressures from potential environmental legislation or local production bans in China could raise baseline prices. Weakening demand in animal feed is offset by growing consumption in supplements and functional foods. Net result: price trend likely steadies at a new higher baseline, with periodic upswings driven by raw material cost surges or supply bottlenecks.
Market data draws from trade statistics, published quarterly earnings reports from leading global producers, and aggregated production announcements from Asian chemical associations. Price trend modeling references ten-year historical spot and contract pricing, with scenario analysis based on established supply chain disruption and regulatory risk probability.
Recent seasons saw Chinese crackdowns on non-compliant fermentation operations, taking marginal capacity offline. Major producers increased investment in energy recovery and waste minimization, aiming for cost control and compliance with export market requirements. Indian and Southeast Asian producers expanded technical-grade output, signaling a gradual shift in global supply dynamics.
Stringency in US and EU documentation standards increased. New audit checkpoints for allergen status, GMO residue management, and dioxin monitoring add complexity to certification cycles. Pharmaceutical buyers now frequently require cross-checking against latest pharmacopeia revisions, requiring process updates and additional analytical method validation on the manufacturer side.
Reliable manufacturers now deploy advanced process risk management, investing in in-line monitoring, batch-level genealogy tracking, and rapid-release analytical suites. Flexibility in switching packaging format, shipping routing, and emergency sourcing agreements with major input suppliers reduce lead time risk. Integrated environmental mitigation has become a production prerequisite for export eligibility, especially to OECD markets.
As a manufacturer, we engage daily with formulation teams from across sectors that utilize vitamin C. The ascorbic acid molecule serves unique purposes depending on the industry’s context and product specs. Each segment drives process controls and grade selection based on downstream application and regulatory exposure.
| Application Area | Common Grade(s) | Key Parameters Shaping Grade Choice |
|---|---|---|
| Food & Beverage Fortification | Food Grade (FCC/E300, JP, USP) | Heavy metal content, oxalic acid content, clarity in final solution, flavor profile impact, lot-to-lot consistency, allergen control. Especially sensitive to impurities and trace solvents. Regulatory compliance with food codices and specific destination country requirements. |
| Pharmaceutical Preparations | Pharma Grade (USP/EP/JP/BP) | Endotoxin load, particulate inspection, residual solvents, bio-burden control. Tight release limits for process-related and element impurities. Production uses controlled cleanroom environment and validated process routes with batch traceability. |
| Feed Additives | Feed Grade | Elemental purity, dioxin monitoring, antimicrobials residue profile, blending characteristics in premix, sensitivity to moisture, dusting potential. Country-specific regulatory requirements influence allowable contaminants and additional in-process tests (antibiotic residues, mycotoxins). |
| Cosmetic/Personal Care | Cosmetic Grade | Color index, odor, trace metals, stability under processing pH, granulometry for dispersibility in creams/serums. Cleanroom processing and microbial controls are commonly required as per customer standards. |
| Industrial/Technical Uses | Industrial Grade | Impurity tolerance typically higher. Particle size and bulk density influence handling and mixing in non-consumable products. Cost control often prioritized over purity, except in precision applications like film or polymer additive uses where certain impurities may be problematic. |
Production lines are established based on end-use, dictated by raw material screening and environmental control levels. For food and pharma grades, raw inputs are stringently sourced, tracked, and qualified to reduce introduction pathways for heavy metals or process-specific contaminants. Feed and industrial grades allow for wider incoming raw material bands, provided the route remains free of banned substances for their typical markets.
Grade selection always hinges on two pivots: impurity profile and handling properties. Food and pharma applications strictly limit lead, arsenic, and cadmium levels, validate microbial counts, and set boundaries for residual process-related solvents. Physical characteristics such as powder flow and granular size assist in downstream blending, dissolution, and packaging, where the need for dust-free operations or rapid aqueous clearance guides the preferred cut or granulation.
Start by establishing whether the final product enters human consumption, animal feed, or a technical process. Cross-link the end-user’s regulatory context for every country the product will enter, as legislative authorities may upgrade local requirements at any time.
Verify target regulatory frameworks—such as FCC, USP, JP, EP, or regional feed standards. Confirm whether contaminants, process residue, and microbiological limits are regulated by law or by downstream audit. Food and pharma batches may face random inspection or mandatory authority releases in some export destinations, triggering the need for validated laboratory support and retained sample protocols.
Engage with quality assurance and R&D leaders to map target purity and impurity bands relevant for your formulation. Unmet limits for key parameters (metal content, microbial load, solvent residue, color index) may disrupt or delay release, particularly in finished goods failing internal or customer audits. Custom pack sizes, variant granulometry, or tailor-made impurity profiles can generally be assessed at this stage, subject to advance request and contract volume.
Costs lean heavily on volume commitments and grade requirements. Production prioritizes lot consolidation and full-run scale where annual take-off is firm. Budget permitting, custom grades or high-purity lots can be set up, balancing extra purification costs against anticipated sales.
No plant trial, new formulation, or regulatory submission proceeds without actual sample validation. Send a request for manufacturer-origin samples, accompanied by full CoA and batch traceability. Plant or laboratory use of the received material under real conditions (dissolution, blending, stability) allows for confirmation of grade suitability or highlights any issues requiring process or sourcing changes ahead of launch or scale-up.
Manufacturing vitamin C for food, feed, and pharmaceutical markets demands strict discipline across every step of the process. Typical operations maintain certified quality management systems such as ISO 9001 to align site controls with both regulatory and customer-specific requirements. These certifications anchor process performance records, complaint handling, and continuous improvement systems. Customers sourcing for regulated applications, such as OTC medicines or infant formula, often request audit access or require supplementary GMP certification, reflecting the increased scrutiny within those sectors.
Certification history for each batch depends on its intended end use. For pharmaceutical grades, compliance with established pharmacopeia monographs (USP, EP, JP, etc.) guides analytical testing, release thresholds, and documentation. Food and feed grades often require audit trails showing conformity with FSSC 22000 or ISO 22000. Halal, Kosher, and allergen declarations are separately managed for supply into specialty segments. Certification portfolios are routinely re-evaluated to reflect ongoing changes in regulatory or market drivers.
Each lot ships with a Certificate of Analysis referencing test criteria and accepted limits based on the agreed specification. Analytical data reflect methods validated according to international best practices, with reference standards maintained in-house for calibration and verification. Upon customer request, manufacturing documentation packages may include full traceability outlines, batch processing histories, and impurity profiling results. Routine document retention ensures regulatory trace-back capability if required during post-market surveillance or compliance audits.
Securing steady supply begins with a transparent look at committed production capacities and planned expansions. Facilities prioritize core volume allocation to anchor customers and provide flexibility to pivot capacity for volume swings tied to seasonal or regional market conditions. Discussion of annual purchase volume, delivery cycling, and contingency stock solutions opens a path to mutually predictable supply arrangements. Alternative contract modes—spot, scheduled call-off, and rolling forecast—can be structured to support different risk positions or forecasting models.
Sustaining uninterrupted output for vitamin C draws on integrated process management and raw material risk mapping. Key input materials are qualified through dual sourcing programs, and holding tanks or finished goods warehouses buffer against variability or downtime. Operations use a release protocol that locks batch movement until end release criteria are confirmed, with ongoing process monitoring designed to avoid drift beyond agreed standards. Continuous investment in bottleneck elimination and in-process automation enhances both capability and year-round output reliability.
Sample application follows a straightforward pathway: inquiry receipt triggers technical review of the grade, use scenario, and documentation needs. Standard evaluation samples are prepared, with retained reference material stored to support any further investigative analysis. Application forms capture required detail about end usage, regulatory exposure, and specification alignment, allowing cross-validation with internal release benchmarks before shipment. Where custom testing or documentation is needed, scope and timing are confirmed directly with the requestor.
No two customers manage requirements or volatility in the same way. For direct buyers seeking buffer stock or just-in-time supply, consignment inventory or bonded warehouse solutions streamline handover while limiting exposure to demand uncertainty. Flexible cooperation also covers consigned vendor-managed inventory or volume-linked rebate programs for long-term partners, with supply commitments tailored to their market access conditions. All such arrangements depend on clear sharing of planning data and periodic realignment to keep pace with changing business realities.
In recent years, industrial vitamin C (ascorbic acid) R&D activity has focused on process intensification, impurity control, and adaptation for diversified downstream requirements. Enzymatic conversion continues to draw significant investment as manufacturers seek to reduce operational costs by limiting solvent use and simplifying purification. For feed and food-grade Vitamin C, attention is on particle morphology and surface modification to support direct compression, rapid dissolution, and improved stability in final products. In effervescent and beverage applications, developers scrutinize oxidative degradation pathways under various packaging and humidity conditions.
Beyond traditional food and pharmaceutical markets, technical teams monitor clinical nutrition and cosmetic sectors for new formulation approaches demanding higher-purity, ultra-low metal content, or particulate Vitamin C. Animal nutrition, feed premixes, and aquaculture present new formulation challenges, especially around multi-component blends with trace mineral compatibility. Trends in biodegradable packaging and functional foods push for specialized grades with enhanced shelf life or microencapsulation.
Industrial facilities face persistent process control challenges where residual byproducts (levulinic, oxalic acids, trace heavy metals) can complicate downstream compliance. Breakthroughs in continuous crystallization and membrane filtration have demonstrated potential to achieve finer impurity profiles and reduce batch-to-batch variability. For pharmaceutical-grade Vitamin C, meeting global pharmacopoeial standards demands robust in-line monitoring during drying and packaging. Routine sampling and root-cause analysis address the risk of degradation linked to exposure to heat, light, and trace oxygen during handling.
The global vitamin C market exhibits steady demand growth in core regions fueled by nutraceuticals, functional drinks, immunity-boost products, and cosmetic formulations. Production expansion, especially in Asia, marks increased competition but also raises supply chain resilience. Customer requests increasingly differentiate by segment—some requiring highly specialized specifications, others focusing on logistics and cost effectiveness.
Process trends lean toward hybrid biotechnological and chemical synthesis routes, supporting cost management and yield improvement. Patterned investments in automation increase throughput and traceability. Sensors and in-line analytics offer tighter process control, driving higher consistency and facilitating root-cause interventions. Technologies enabling particle size and surface property adjustment keep pace with tailored requirements for tablet, powder, and liquid end-uses.
Reduction of chemical waste, water use, and greenhouse emissions guides raw material sourcing and process route evaluation. Selection of renewable carbohydrate feedstocks for the two-step fermentation process is under expanded evaluation. Targeted solvent recycling, energy optimization in crystallization/drying, and development of greener extraction aids are regular discussion points in industrial R&D forums. Environmental compliance and audit-readiness feature in annual improvement plans, with supplier audits and life-cycle analysis influencing purchasing and process modification decisions.
Throughout product development and scale-up projects, technical personnel advise on formulation compatibility, impurity management, and transition strategies using batch data, performance analytics, and laboratory validation where necessary. Recommendations are customized based on actual application needs and compliance environments.
Collaborations with formulation chemists and process engineers support integration of Vitamin C grades into complex blends and sensitive dosage forms, with specific suggestions for pre-mixing, anti-caking, stabilization, and performance adjustment by application. Feed and dietary supplement producers may discuss granule flowability, homogeneity in multi-component mixes, and synergistic antioxidant systems. Documentation and support extend to solubility, dissolution, and shelf-life verification for direct consumption or further downstream use.
Service protocols include batch-specific documentation, material traceability reports, and technical assistance for handling and storage adaptation under actual site conditions. Feedback loops through customers and downstream users inform continuous improvement for both product and process adjustments. Support covers deviation investigations, root-cause at-use failures, and assistance in regulatory documentation. The release standard follows internal quality control criteria in line with agreed specification and customer requirements, with adjustments possible by grade, regional, or regulatory expectations.
Our facility focuses on the large-scale synthesis of ascorbic acid, commonly recognized as Vitamin C, for industrial and commercial applications. The process starts with glucose sourced from vetted agricultural origins, which we convert through a controlled fermentation process, followed by purification and crystallization. Every step takes place within our own plant, from the initial fermentation to the final drying and sizing. We employ automated technology for precise control over process variables, supporting high-volume, uninterrupted production with stable output parameters.
Vitamin C finds constant demand in food and beverage fortification, pharmaceutical formulation, animal nutrition, and cosmetics manufacturing. Food processors rely on its antioxidant properties to preserve flavors and oils in products ranging from juices to meat products and confectionery. Pharmaceutical firms use it as an essential API in multivitamin tablets, effervescents, and syrups. Animal feed producers integrate our ascorbic acid into premixes and concentrate blends to support livestock health. In personal care manufacturing, it stabilizes sensitive formulations and supports claims for skin health. Every batch leaves our plant with the physical and chemical profile required for these end-uses.
We maintain ISO-compliant routine analysis covering assay, particle sizing, moisture, pH, and impurity profile on every lot. Every shift samples in-process intermediates to track conversions and isolate deviations early. Our quality lab operates HPLC, UV spectrophotometers, and titration equipment, retaining archived lot samples for traceability. Finished product packing lines receive only material that passes physical inspection and chemical conformity. Audit trails cover every shipment lot, linking raw material intake to finished goods dispatch. This approach secures consistent performance for customers’ operations, with documented and repeatable results in automated dosing, dry blending, and liquid dispersions.
Material leaves our factory in multiple configurations: 25 kg fiber drums with inner liners, 10 kg cartons, and specialty bulk sacks for automated plants. High-speed filling stations operate under GMP-compliant procedure with online weight verification. We offer vacuum-sealed, heat-sealed, and nitrogen-flushed options depending on material sensitivity and shelf life requirement. Finished goods storage operates both ambient and climate-controlled areas, allowing prompt allocation for urgent or scheduled orders alike. Direct container loading and palletizing facilities enable uninterrupted supply for both regional and international demand, with cargo tracking available for all shipments.
We provide process integration guidance during product trials and formulation upgrades. Customers’ technical teams collaborate directly with our process chemists and engineers to address dispersibility, reactivity in complex matrices, and compatibility in automated dosing systems. On-site assistance is available for scale-up, line commissioning, and troubleshooting. Our analytical laboratory supports joint method validation for QC programs, aligning specifications with plant process data for minimum downtime and reduced production variation.
Buying directly from our plant reduces intermediaries, controlling landed cost and shortening lead time. Consistent batch quality lowers production blockages and supports tighter finished product guarantees for food and pharma manufacturers. Distributors handling forward stocks benefit from extended shelf life and stable turnover, thanks to our packaging stability data and batch tracking. Procurement professionals receive technical dossiers, audit summaries, and advance production notices to align deliveries with operational cycles. Our direct production and shipment framework allows supply chain transparency and volume flexibility during both peak and low-demand cycles.
| Production Feature | Business Impact |
|---|---|
| In-house synthesis and packaging | Direct quality control and batch traceability |
| Automated process monitoring | Stable output and minimized off-spec batches |
| Multiple packaging formats | Efficient bulk handling and operational flexibility |
| Technical problem-solving team | Faster scale-up and process troubleshooting |
| Batch-level QA documentation | Simplified compliance for regulated sectors |
Our continuous investment in production technology and quality management anchors reliability for commercial and industrial Vitamin C users operating under strict process and compliance pressures.
Reliable information about ingredient concentration and source has become essential for every customer, whether in the nutrition, food, or pharma sectors. In the case of Vitamin C — also labeled as ascorbic acid — confusion often arises over whether a product uses a synthetic or natural origin, as well as the exact concentration. In our production facility, we address these questions with open disclosure and technical rigor drawn from our years of work in bulk ingredient synthesis.
Within the global supply chain, almost all commercially produced Vitamin C results from synthetic fermentation, beginning with glucose. Our process follows this industry standard: after the fermentation of glucose using microbial pathways, ascorbic acid crystallizes and undergoes a stringent set of purification steps. The natural and synthetic forms of Vitamin C are chemically identical in molecular structure and activity; differences often trace back to marketing claims rather than science. While some producers claim “natural Vitamin C” extracted from fruit sources, the concentration and scale required for industrial applications make fermentation-based synthetic production the only practical method for providing consistent, large-volume supply with robust quality control.
Source labeling matters for transparency and regulatory conformance. We clearly indicate synthetic origin whenever required for regulatory markets or customer preference. Our labels reflect the reality of large-scale ingredient production without hiding behind vague “natural” language that cannot be substantiated for industrial volumes.
Our standard Vitamin C product is supplied as a crystalline powder, with concentration not less than 99% pure ascorbic acid on a dry basis. Each production lot undergoes HPLC and titration procedures in our on-site QA laboratory. Certificates of Analysis accompany every batch, providing plain data on purity and assay value. Impurities and degradation products are tightly controlled and measured to parts-per-million thresholds, which align with major pharmacopeial and food safety standards. Our product fits the requirements for use in food fortification, beverage manufacturing, pharmaceutical tableting, and cosmetic formulations. Blends or granules can be milled, coated, or pre-mixed per customer’s functional requirements, and we provide technical support throughout the project lifecycle for both R&D and commercial production runs.
Misunderstandings often arise due to misrepresentation or deliberate obfuscation. Some imagine synthetic Vitamin C as being inferior or less effective. The industry’s long safety record and the vast volume of published research confirm there is no functional difference in vitamin activity, provided the substance is L-ascorbic acid exceeding the accepted assay range. Our process guarantees this analyte profile, with full batch traceability from fermentation through to packaging.
Beyond publishing numbers, we believe in direct engagement with our customers. Our technical team supports custom documentation, detailed analyses, and tailored handling, should stricter regulations or proprietary requirements arise in specialized industries like infant powder, clinical nutrition, or sterile compounding. For clients requiring non-standard declarations or further technical proof, we share our process flow documentation, compositional batch data, and regulatory statements. Collaboration leads to clarity and confidence in raw materials — essential for audit compliance and long-term process reliability.
By controlling our entire synthetic production chain, we provide a level of consistency and accountability unachievable by fragmented suppliers or resellers. This lets our customers plan production schedules, regulatory files, and new product launches with confidence in ingredient truth and traceability. Vitamin C delivered from our factory stands as a benchmark of direct manufacturing integrity and clear technical communication.
Every year, global demand for Vitamin C climbs in step with growing focus on health and wellness across pharmaceutical, food, and personal care industries. From our vantage as a direct manufacturer, these volumes and timelines matter not just as a logistics detail but as a real-world issue impacting planning, product launches, and warehouse operations on both ends of the supply chain.
For Vitamin C, minimum order quantity (MOQ) starts from a simple premise: ensuring efficiency and predictability from our production line to your facility. High-volume synthesis calls for multi-ton batch runs to justify set-up and operational costs. Our MOQ for Vitamin C ascorbic acid stands at 1 metric ton for a single grade or specification. This reflects both raw material purchasing constraints and downstream logistics. We fill standard 25kg fiber drums or kraft paper bags, palletizing for stable, secure transport. Each batch undergoes the same rigorous QA/QC protocols, regardless of packed quantity, because uneven controls introduce unacceptable risk.
MOQ sometimes draws feedback from new market entrants or those developing pilot projects. We have seen many cases where scaling from laboratory or local distribution to broader market needs hits bottlenecks at the procurement stage. Smaller batch requests can be handled in rare situations after careful coordination, but this adds to cost and prolongs lead time due to line changeover, cleaning verification, and packaging setup. We encourage customers launching new products or exploring fresh applications to consider forward planning—MOQ reflects risk and cost management, not inflexibility. Our technical sales team works closely with clients to navigate that transition from concept to commercial quantity.
Actual production lead time for Vitamin C depends on current plant utilization and global availability of raw precursors such as glucose. For standard product grades, lead time runs three to four weeks from confirmed order and payment. This covers manufacturing, quality testing, and export documentation. Seasonal factors like increased winter demand or annual maintenance cycles at our plant push lead time out by several days. Stockpiled finished product sometimes shortens the wait, but for custom grades or specific micronized sizes, full production windows should be expected.
Global shipping disruptions over the past years have shown just how much reliability matters. Our logistics department tracks spot rates and transit times to major ports. Customers with fixed formulation dates or market launches must account for not just production lead time but also customs clearance, inland transfer, and destination-side handling. Collaborative scheduling, especially on standing orders or blanket contracts, helps us maintain secure supply and on-time performance.
Success in a manufacturing environment comes from consistency—consistent processes, consistent communication, consistent supply. We encourage partners to provide rolling forecasts and estimated usage windows. This advance visibility allows us to secure upstream raw materials at the best rates and block out dedicated line time. Rush or emergency orders can sometimes be slotted in, but unplanned demand strains every point along the chain, from raw material procurement to outbound freight. Experience tells us: advanced planning gives both sides best value, and helps manage external risks.
As a manufacturer, our commitment to our customers goes beyond just a price per kilo. We offer transparency on order policies, proactive communication about lead times, and clear expectations for logistics. Vitamin C production involves dozens of process steps, hundreds of tons of input, and regulatory attention across regions. Getting MOQ and lead time right is the difference between smooth supply and real-world business disruption. We take that seriously, every single order.
As a manufacturer specializing in high-purity Vitamin C, we face a dynamic regulatory landscape with every shipment. Each market presents its own set of import regulations, from ingredient identity to purity thresholds and labeling requirements. We keep our certifications and documentation current and align with established benchmarks such as the Food Chemicals Codex (FCC) or European Pharmacopoeia (EP), since these are often requested by regulatory agencies at customs.
From experience, customs inspections target traceability, grade designation, and compliance with allergen statements or potential contaminants. Our technical team maintains a robust documentation system, including batch-specific Certificates of Analysis, origin declarations, and Material Safety Data Sheets to support the clearance process. We also review and update labeling and safety statements for compliance with the destination country’s language and local requirements.
Ascorbic acid, the core of Vitamin C, is prone to oxidation and degradation when exposed to high temperatures, light, and moisture. Over years of production and international shipping, we have observed that product stability depends on controlling these environmental factors from our facility to the customer’s door.
Our product leaves the factory floor in vacuum-sealed, moisture-proof packaging. This minimizes risk from ambient humidity and air. We use light-shielding outer packaging and avoid clear plastics that could let in UV or bright light during transit. Once sealed, our Vitamin C is boxed inside lined, reinforced cartons and then secured on pallets.
Storage and transportation in temperature-controlled containers extend shelf life. For large sea freight consignments, we recommend transport under 25°C. In hotter climates, or in summer months, we coordinate with our logistics partners for reefer containers, reducing exposure to temperature spikes.
Moisture introduces the greatest risk. If sweat forms inside a container, even micro-level ingress can reduce potency. Our standard practice uses desiccant bags in each drum, extra moisture-barrier liners for international shipments, and frequent checks of container seals before loading. Once dispatched, we track deliveries and stay in communication with freight handlers, providing real-time instructions if unexpected delays or rerouting occur.
Many customers request documentation that tracks chain-of-custody, including temperature logs or shipment route details for sensitive batches. Our supply chain team incorporates this into our standard process, especially when fulfilling orders for dietary supplement and pharmaceutical manufacturers. Quality assurance does not end at our loading dock; we maintain oversight until the product safely reaches the importing facility.
Every batch released is produced and packed in accordance with HACCP and GMP standards. Mock recalls and retention sampling policies allow us to deliver reliable traceability and peace of mind. When local authorities seek confirmation of regulatory compliance, we provide written evidence and respond with technical data drawn directly from our own analytical records.
International regulations shift with consumer trends, scientific advances, and trade policy. We invest in professional monitoring of all export markets, participate in industry associations, and regularly review the impact of legislative changes on our process. Our documented procedures allow for rapid adjustment so that compliance remains a constant, not a variable. Our commitment to safe delivery and reliability stands behind every shipment of Vitamin C we produce.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales7@bouling-chem.com, +8615371019725 or WhatsApp: +8615371019725
